CLINICAL_TRIALS
trial_result
· 2017-11-17
Clinical Trial Update: An Open-Label Safety Study of A-101 Solution [Phase 3]
Summary
Phase 3 open-label safety study of A-101 Solution completed; results posted in 2017 for seborrheic keratosis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Aclaris Therapeutics, Inc. | Conditions: Seborrheic Keratosis | Phase 3 | Status: COMPLETED | Results posted: 2017-11-17